Cellceutix Announces Details for Upcoming Investor
Post# of 72440
(Total Views: 376)
Posted On: 04/19/2017 4:20:09 PM
Cellceutix Announces Details for Upcoming Investor and Shareholder Presentations
BEVERLY, MA – April 19, 2017 (GLOBE NEWSWIRE) Cellceutix Corporation (OTCQB: CTIX), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory and antibiotic applications, provides additional details for upcoming investor and shareholder presentations.
On the morning of April 20, 2017, at 11AM Eastern (EDT), a pre-recorded presentation, audio and corresponding slide deck, with particular emphasis given to Brilacidin interim trial results in Inflammatory Bowel Disease and Oral Mucositis, will be made available at the Events and Presentation section of the company’s website, linked to below:
http://www.cellceutix.com/new-events-and-presentations/
Additionally, the Company is fielding investor and shareholder questions in advance of a live conference call, scheduled for June 8, 2017 at 11AM EDT, as follow-up to the next quarterly report (10-Q) to be released in May. Questions for the June call may be submitted in advance by emailing conference@cellceutix.com to be received by June 1, 2017. Dial-in instructions for participants will be announced one week prior.
BEVERLY, MA – April 19, 2017 (GLOBE NEWSWIRE) Cellceutix Corporation (OTCQB: CTIX), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory and antibiotic applications, provides additional details for upcoming investor and shareholder presentations.
On the morning of April 20, 2017, at 11AM Eastern (EDT), a pre-recorded presentation, audio and corresponding slide deck, with particular emphasis given to Brilacidin interim trial results in Inflammatory Bowel Disease and Oral Mucositis, will be made available at the Events and Presentation section of the company’s website, linked to below:
http://www.cellceutix.com/new-events-and-presentations/
Additionally, the Company is fielding investor and shareholder questions in advance of a live conference call, scheduled for June 8, 2017 at 11AM EDT, as follow-up to the next quarterly report (10-Q) to be released in May. Questions for the June call may be submitted in advance by emailing conference@cellceutix.com to be received by June 1, 2017. Dial-in instructions for participants will be announced one week prior.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼